BioLife Solutions, Inc. Operating Lease Right-of-Use Assets
BioLife Solutions, Inc. (BLFS) had Operating Lease Right-of-Use Assets of $8.64 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $8.64M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.11M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $7.47M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $7.63M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $8.64M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $7.11M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $7.47M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $7.63M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $9.53M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $10.13M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $10.55M 10-K · filed 2026-02-26 | $10.67M 10-K · filed 2025-03-03 |
| 2024-09-30 | $14.40M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.40M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $10.78M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $6.88M 10-K · filed 2025-03-03 | $11.45M 10-K · filed 2024-02-29 |
| 2023-09-30 | $12.65M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $14.94M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $15.59M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $15.29M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $15.83M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $17.31M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $18.16M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $18.70M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $17.16M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $17.40M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $10.52M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $9.68M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $585.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $740.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $892.00K 10-Q · filed 2020-05-29 | |
| 2019-12-31 | $1.04M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $1.18M 10-K · filed 2020-05-15 | |
| 2019-06-30 | $1.08M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $1.20M 10-Q · filed 2019-05-09 | |
| 2019-01-01 | $1.30M 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |